It is worth to mention that a Peruvian cohort, the largest in Latin America, affirms that possible cross-reactions of IgM/IgG-DENV rapid test results concerning antibodies developed after infection with SARS-CoV-2 are not ruled out when describing cases of false positives in rapid tests DENV [18]. This evidence concerns the gene CD40LG and infection.